Page last updated: 2024-09-03
3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and Spinal Cord Injuries
3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol has been researched along with Spinal Cord Injuries in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Gwak, SJ; Ha, Y; Kim, KN; Yoon, DH; Yun, Y | 1 |
Other Studies
1 other study(ies) available for 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and Spinal Cord Injuries
Article | Year |
---|---|
Therapeutic Use of 3β-[N-(N',N'-Dimethylaminoethane) Carbamoyl] Cholesterol-Modified PLGA Nanospheres as Gene Delivery Vehicles for Spinal Cord Injury.
Topics: Animals; Biological Transport; Cholesterol; Gene Expression; Gene Transfer Techniques; Genetic Therapy; Injections, Spinal; Lactic Acid; Male; Mice; Motor Activity; Nanospheres; Neovascularization, Physiologic; Neural Stem Cells; Polyethyleneimine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord; Spinal Cord Injuries; Transgenes; Vascular Endothelial Growth Factor A | 2016 |